Aaron Ondrey
Director of Finance/CFO presso ROCKET PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Aaron Ondrey is currently the Chief Financial Officer at Rocket Pharmaceuticals, Inc. He previously worked as the Executive Director-Commercial Finance at Regeneron Pharmaceuticals, Inc. from 2010 to 2018.
Additionally, he served as the Chief Financial Officer & SVP-Financial Planning at Mirati Therapeutics, Inc. from 2022 to 2024.
Mr. Ondrey obtained his undergraduate degree from Case Western Reserve University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2024 | 46 781 ( 0.05% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Aaron Ondrey
| Società | Posizione | Inizio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director of Finance/CFO | 26/03/2024 |
Precedenti posizioni note di Aaron Ondrey
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Director of Finance/CFO | 23/01/2024 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2018 |
Formazione di Aaron Ondrey
| Case Western Reserve University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Aaron Ondrey
